News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
03-Nov-2009 - PharmaCell B.V. has appointed Mr. Alexander Vos as Chief Executive Officer, effective November 1st 2009. Mr. Vos has 20 years of leadership experience in the pharma and biotech industry. He joins from PAION AG, where he was a Member of the Management Board (“Vorstand”) and Chief Operating Officer ...
22-Oct-2009 - Crucell N.V. announced that detailed results of the Phase II Philippines study of its rabies monoclonal antibody combination (CL 184) were presented at the XX Rabies in the Americas (RITA) Conference in Quebec, Canada. The presentation was given by Dr Beatriz P. Quiambao (MD), Chief Clinical ...
16-Oct-2009 - Nobilon, the human vaccine business unit of Schering-Plough Corporation, announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use. “We are encouraged by the continuation of the clinical ...
25-Sep-2009 - OctoPlus N.V. announced that it will reduce its work force by approximately 25% while retaining its revenue guidance for the year. Reductions will occur across all areas of the Company and have taken place in consultation with the Company's Works Council. The reduced headcount will not impact ...
21-Sep-2009 - QIAGEN announced that it has acquired additional licenses from Roche and Idaho Technology related to the use of instrumentation and reagents for PCR-based molecular testing. Financial details were not disclosed. The agreements cover thermal cycler rights and real-time polymerase chain reaction ...
14-Sep-2009 - OctoPlus N.V. announced that it has signed a pharmaceutical development and manufacturing contract with a new client, Axentis Pharma AG. The undisclosed contract value contributes to OctoPlus' annual revenues, for which the Company reiterates its guidance of € 19 million. Under the contract ...
01-Sep-2009 - Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an ...
27-Aug-2009 - OctoPlus N.V. announced that Joost Holthuis has decided to step down as Chief Scientific Officer after successfully leading the Company for almost 15 years since he founded OctoPlus in 1995. The Company will continue to have access to Mr. Holthuis' experience and expertise on a consultancy ...
26-Aug-2009 - TTY Biopharm will become a co-development partner of to-BBB for the manufacturing of brain-targeted doxorubicin liposomes. These liposomes are essential for the clinical development of to-BBB’s lead product for the treatment of brain cancer. Werner Gladdines, Head of Clinical Operations at ...
19-Aug-2009 - A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis. A total budget of nearly 3.6 million euros has been allocated over the next 4 years, to develop effective drugs for these diseases. The consortium ...
© 1997-2024 LUMITOS AG, All rights reserved